Advertisement

Clinical Evaluation and Staging of Oral Cancer

  • Christina MimikosEmail author
  • Sudhir Nair
  • David Cohan
Chapter

Abstract

The identification and evaluation of the patient with oral cavity cancer is an inherently multidisciplinary proposition. For most patients, the initial identification and evaluation of an oral lesion is undertaken by a primary healthcare giver—dentists, primary care physicians, oral surgeons, and general practitioners—before referring to a tertiary care center. Accurate diagnosis and staging at the initial visit is vital to appropriate decision-making and treatment planning. It is critical that the first examination of the oral cancer patient be comprehensive. Equally important is that the history taken is complete and elicits pertinent details that will give the oncologic care providers information that will be relevant to the care of the patient. Initial evaluation of the oral cavity cancer patient will not only result in tumor staging but also provide information about the most appropriate interventions and identify comorbidities that may influence treatment choices. Attempt also should be made to elicit social support network the patient has to facilitate treatment and surveillance.

Keywords

Oral Cavity Tumor Thickness Alveolar Ridge Verrucous Carcinoma Oral Cancer Patient 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

References

  1. 1.
    Chen AM, Chen LM, Vaughan A, et al. Tobacco smoking during radiation therapy for head-and-neck cancer is associated with unfavorable outcome. Int J Radiat Oncol Biol Phys. 2011;79(2):414–9.CrossRefPubMedGoogle Scholar
  2. 2.
    Hoff CM, Grau C, Overgaard J. Effect of smoking on oxygen delivery and outcome in patients treated with radiotherapy for head and neck squamous cell carcinoma – a prospective study. Radiother Oncol. 2012;103(1):38–44.CrossRefPubMedGoogle Scholar
  3. 3.
    Deleyiannis FW, Tomas DB, Vaughan TL, et al. Alcoholism: independent predictor of survival in patients with head and neck cancer. J Natl Cancer Inst. 1996;88:542–9.CrossRefPubMedGoogle Scholar
  4. 4.
    Ang KK, Trotti A, Brown BW, et al. Randomized trial addressing risk features and time factors of surgery plus radiotherapy in advanced head-and-neck cancer. Int J Radiat Oncol Biol Phys. 2001;51(3):571–8.CrossRefPubMedGoogle Scholar
  5. 5.
    Flint PW, Haughey BH, Lund VJ, et al. Cumming otolaryngology head and neck surgery. Philadelphia: Mosby Elsevier; 2010. Print.Google Scholar
  6. 6.
    Koch WM, Lango M, Sewell D, et al. Head and neck cancer in nonsmokers: a distinct clinical and molecular entity. Laryngoscope. 1999;109(10):1544–51.CrossRefPubMedGoogle Scholar
  7. 7.
    Gupta B, Johnson NW. Systematic review and meta-analysis of association of smokeless tobacco and of betel quid without tobacco with incidence of oral cancer in South Asia and the Pacific. PLoS One. 2014;9(11):e113385.CrossRefPubMedPubMedCentralGoogle Scholar
  8. 8.
    Khode SR, Dwivedi RC, Rhys-Evans P, et al. Exploring the link between human papillomavirus and oral and oropharyngeal cancers. J Cancer Res Ther. 2014;10(3):492–8.PubMedGoogle Scholar
  9. 9.
    National Comprehensive Cancer Network. Oral cavity cancer (version 2.2014). http://www.nccn.org/professionals/physician_gls/pdf/head-and-neck.pdf. Accessed 19 Dec 2014.
  10. 10.
    De Souza C, Pawar U, Chaturvedi P. Precancerous lesions of the oral cavity. Otolaryngol Clin. 2009;1(1):7–14.Google Scholar
  11. 11.
    Pallagatti S, Sheikh S, Aggarwal A, et al. Toluidine blue staining as an adjunctive tool for early diagnosis of dysplastic changes in the oral mucosa. J Clin Exp Dent. 2013;5(4):e187–91.CrossRefPubMedPubMedCentralGoogle Scholar
  12. 12.
    Vashisht N, Ravikiran A, Samantha Y, et al. Chemiluminescence and toluidine blue as diagnostic tools for detecting early stages of oral cancer: an in vivo study. J Clin Diagn Res. 2014;8(4):ZC35–8.PubMedPubMedCentralGoogle Scholar
  13. 13.
    The American Joint Committee on Cancer. 7th ed. http://www.cancer.gov/cancertopics/pdq/treatment/lip-and-oral-cavity/HealthProfessional/page3. Accessed 19 Dec 2014.
  14. 14.
    Belcher R, Hayes K, Fedewa S, et al. Current treatment of head and neck squamous cell cancer. J Surg Oncol. 2014;110(5):551–74.CrossRefPubMedGoogle Scholar
  15. 15.
    Thiagarajan S, Nair S, Nair D, et al. Predictors of prognosis for squamous cell carcinoma of oral tongue. J Surg Oncol. 2014;109(7):639–44.CrossRefPubMedGoogle Scholar
  16. 16.
    Moore C, Juhns JG, Greenberg RA. Thickness as a prognostic aid in upper aerodigestive tract cancer. Arch Surg. 1986;121:1410–4.CrossRefPubMedGoogle Scholar
  17. 17.
    Jadhave KB, Gupta N. Clinicopathological prognostic implicators of oral squamous cell carcinoma: need to understand and revise. N Am J Med Sci. 2013;5(12):671–9.CrossRefGoogle Scholar
  18. 18.
    Huang SH, Hwang MB, Lockwood G, et al. Predictive value of tumor thickness for cervical lymph node involvement in squamous cell carcinoma of the oral cavity. Cancer. 2009;115(7):1489–97.CrossRefPubMedGoogle Scholar
  19. 19.
    Massona J, Regateiro FS, Janurio G, et al. Oral squamous cell carcinoma: review of prognostic and predictive factors. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2006;102:67–76.CrossRefGoogle Scholar
  20. 20.
    Low TH, Gao K, Elliot M, et al. Tumor classification for early oral cancer: re-evaluate the current TNM classification. Head Neck. 2013;23.Google Scholar
  21. 21.
    Pentenero M, Gandolfo S, Carrozzo M. Importance of tumor thickness and depth of invasion in nodal involvement and prognosis of oral squamous cell carcinoma: a review of the literature. Head Neck. 2005;27(12):1080–91.CrossRefPubMedGoogle Scholar
  22. 22.
    Ebrahimi A, Gil Z, Amit M, et al. Primary tumor staging for oral cancer and a proposed modification incorporating depth of invasion: an international multicenter retrospective study. JAMA Otolaryngol Head Neck Surg. 2014;140(12):1138–48.CrossRefPubMedGoogle Scholar
  23. 23.
    Anneroth G, Batsakis J, Luna M. Review of literature and recommended system of malignancy grading in oral squamous cell carcinomas. Scand J Dent Res. 1987;95:229–49.PubMedGoogle Scholar
  24. 24.
    Akhter M, Hossain S, Rahman QB, et al. Study on histological grade of oral squamous cell carcinoma and its co-relationships with regional metastasis. J Oral Maxillofac Pathol. 2011;15:168–76.CrossRefPubMedPubMedCentralGoogle Scholar
  25. 25.
    Carrillo JF, Carrillo LC, Cano A, et al. A retrospective cohort study of prognostic factors in patients with squamous cell carcinoma of the oral cavity and oropharynx. Head Neck. 2016;38(4):536–4.Google Scholar
  26. 26.
    Wallis S, Stafford N, Greenman J. The clinical relevance of immune parameters in the tumor microenvironment of head and neck cancers. Head Neck. 2015;37(3):449–59.Google Scholar
  27. 27.
    Jardim JF, Francisco AL, Gondak R, et al. Prognostic impact of perineural invasion and lymphovascular invasion in advanced stage oral squamous cell carcinoma. Int J Oral Maxillofac Surg. 2015;44(1):23–8.Google Scholar
  28. 28.
    de Araujo RF, Barboza CA, Clebis NK, et al. Prognostic significance of the anatomical location and TNM clinical classification in oral squamous cell carcinoma. Med Oral Patol Oral Cir Bucal. 2008;13(6):E344–7.PubMedGoogle Scholar
  29. 29.
    Mamelle G, Pampurik J, Luboinski B, et al. Lymph node prognostic factors in head and neck squamous cell carcinomas. Am J Surg. 1994;168:494–8.CrossRefPubMedGoogle Scholar
  30. 30.
    Ebrahimi A, Gil Z, Amit M, et al. The prognosis of N2b and N2c lymph node disease in oral squamous cell carcinoma is determined by the number of metastatic lymph nodes rather than laterality. Cancer. 2014;120(13):1968–74.CrossRefPubMedGoogle Scholar
  31. 31.
    Huang SF, Wei FC, Liao CT, et al. Risk stratification in oral cavity squamous cell carcinoma by preoperative CRP and SCC antigen levels. Ann Surg Oncol. 2012;19(12):3856–64.CrossRefPubMedGoogle Scholar
  32. 32.
    Athanassiou-Papaefthymiou M, Shkeir O, Kim D, et al. Evaluation of CD44 variant expression in oral, head and neck squamous cell carcinomas using a triple approach and its clinical significance. Int J Immunopathol Pharmacol. 2014;27(3):337–49.PubMedPubMedCentralGoogle Scholar
  33. 33.
    Nanda DP, Dutta K, Ganguly KK, et al. MMP-9 as a potential biomarker for carcinoma of the oral cavity: a study in eastern India. Neoplasma. 2014;61(6):747–57.CrossRefPubMedGoogle Scholar
  34. 34.
    Kim JW, Roh JL, Park Y, et al. Cytoplasmic iASPP expression as a novel prognostic indicator in oral cavity squamous cell carcinoma. Ann Surg Oncol. 2015;22(2):662–9.Google Scholar
  35. 35.
    Fillies T, Werkmeister R, Packseien J, et al. Cytokeratin 8/18 expression indicates a poor prognosis in squamous cell carcinomas of the oral cavity. BMC Cancer. 2006;6:10–8.CrossRefPubMedPubMedCentralGoogle Scholar
  36. 36.
    Xia X, Du R, Zhao L, et al. Expression of AEG-1 and microvessel density correlates with metastasis and prognosis of oral squamous cell carcinoma. Hum Pathol. 2014;45(4):858–65.CrossRefPubMedGoogle Scholar
  37. 37.
    Bello IO, Soini Y, Salo T. Prognostic evaluation of oral tongue cancer: means, markers and perspectives. Oral Oncol. 2010;46(9):630–5.CrossRefPubMedGoogle Scholar
  38. 38.
    Ritchie JM, Smith EM, Summersgill KF, et al. Human papillomavirus infection as a prognostic factor in carcinomas of the oral cavity and oropharynx. Int J Cancer. 2003;104(3):336–44.CrossRefPubMedGoogle Scholar
  39. 39.
    Lindel K, Beer KT, Laissue J, et al. Human papillomavirus positive squamous cell carcinoma of the oropharynx: a radiosensitive subgroup of head and neck carcinoma. Cancer. 2001;92(4):805–13.CrossRefPubMedGoogle Scholar
  40. 40.
    Montero P, Yu C, Palmer F, et al. Nomograms for preoperative prediction of prognosis in patients with oral cavity squamous cell carcinoma. Cancer. 2014;120(2):214–21.CrossRefPubMedGoogle Scholar
  41. 41.
    Edge SP, Byrd DR, Compton CC, et al., editors. AJCC cancer staging manual. 7th ed. New York: Springer; 2010.Google Scholar

Copyright information

© Springer International Publishing Switzerland 2017

Authors and Affiliations

  1. 1.Department of Head and Neck SurgeryRoswell Park Cancer InstituteBuffaloUSA
  2. 2.Tata Memorial HospitalMumbaiIndia

Personalised recommendations